BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

535 related articles for article (PubMed ID: 18849711)

  • 1. Establishing a threshold for 131I bioassay in nuclear medicine personnel.
    Liang Y; Chu RY; Galbraith WK; Macdurmon GW; Sonnad JR
    Health Phys; 2008 Nov; 95(5 Suppl):S175-9. PubMed ID: 18849711
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A reevaluation of the procedures used to perform thyroid bioassay on nuclear medicine personnel following radioiodine handling procedures.
    Lorah B; King S; Achey B
    Health Phys; 2012 May; 102(5 Suppl 2):S60-2. PubMed ID: 22470001
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A methodology for auto-monitoring of internal contamination by 131I in nuclear medicine workers.
    Vidal MV; Dantas AL; Dantas BM
    Radiat Prot Dosimetry; 2007; 125(1-4):483-7. PubMed ID: 17766259
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of internal exposure of nuclear medicine staff through in vivo and in vitro bioassay techniques.
    Lucena EA; Rebelo AM; Araújo F; Sousa WO; Dantas AL; Dantas BM; Corbo R
    Radiat Prot Dosimetry; 2007; 127(1-4):465-8. PubMed ID: 17681960
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NRC absorbed dose reconstruction for family member of 131I therapy patient: case study and commentary.
    Marcus CS; Siegel JA
    J Nucl Med; 2004 Apr; 45(4):13N-6N, 37N. PubMed ID: 15073236
    [No Abstract]   [Full Text] [Related]  

  • 6. Implications of ICRP 60 and the patient directive 97/43 Euratom for nuclear medicine.
    Bourguignon MH
    Q J Nucl Med; 2000 Dec; 44(4):301-9. PubMed ID: 11302257
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NRC inspections: risk-informed and performance-based.
    Beardsley MR
    J Nucl Med Technol; 2008 Sep; 36(3):129-31; quiz 144. PubMed ID: 18703617
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hand exposure of nuclear medicine workers during administration of radioiodine.
    Wrzesien M; Olszewski J
    Radiat Prot Dosimetry; 2012 Aug; 151(1):147-52. PubMed ID: 22147924
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Minor corrections, clarifying changes, and a minor policy change--NRC. Final rule.
    Fed Regist; 1998 Jul; 63(141):39477-83. PubMed ID: 10181512
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Determination of an environmental background level of 90Sr in urine for the Hanford bioassay program.
    Antonio CL; Rivard JW
    Health Phys; 2009 Nov; 97(5 Suppl):S180-2. PubMed ID: 19820473
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic reference levels for medical exposure of patients: ICRP guidance and related ICRU quantities.
    Rosenstein M
    Health Phys; 2008 Nov; 95(5):528-34. PubMed ID: 18849685
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Review of standards of protection for pregnant workers and their offspring.
    Suárez RC; Berard P; Harrison JD; Melo DR; Nosske D; Stabin M; Challeton-de Vathaire C
    Radiat Prot Dosimetry; 2007; 127(1-4):19-22. PubMed ID: 18079515
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exposure to technologists from preparing and administering therapeutic 131I: how frequently should we bioassay?
    Kopisch A; Martin CB; Grantham V
    J Nucl Med Technol; 2011 Mar; 39(1):60-2. PubMed ID: 21321250
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Criteria for the release of individuals administered radioactive materials--NRC. Final rule.
    Fed Regist; 1997 Jan; 62(19):4120-33. PubMed ID: 10164806
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Finger doses for staff handling radiopharmaceuticals in nuclear medicine.
    Pant GS; Sharma SK; Rath GK
    J Nucl Med Technol; 2006 Sep; 34(3):169-73. PubMed ID: 16951286
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Exposure of relatives of patients after stationary radioiodine therapy by inhalation of 131I in their homes].
    Wellner U; Eschner W; Hillger HW; Schicha H
    Nuklearmedizin; 1998 May; 37(3):113-9. PubMed ID: 9604232
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Canadian National Calibration Reference Center for Bioassay and in Vivo Monitoring: an update.
    Daka JN; Kramer GH
    Health Phys; 2009 Dec; 97(6):590-4. PubMed ID: 19901593
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Occupational exposure in nuclear medicine in Portugal in the 1999-2003 period.
    Martins MB; Alves JG; Abrantes JN; Roda AR
    Radiat Prot Dosimetry; 2007; 125(1-4):130-4. PubMed ID: 17223645
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Radiation cataracts: new data and new recommendations.
    Frey GD
    AJR Am J Roentgenol; 2014 Oct; 203(4):W345-6. PubMed ID: 25247963
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Medical use of byproduct material; policy statement, revision. Nuclear Regulatory Commission. Final policy statement; revision.
    Fed Regist; 2000 Aug; 65(150):47654-60. PubMed ID: 11067710
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.